These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 27090956)
21. Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose. Lee SE; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Lee JW Am J Hematol; 2018 Nov; 93(11):1368-1375. PubMed ID: 30117176 [TBL] [Abstract][Full Text] [Related]
22. [Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia]. Sun C; Lin X; Huang Y; Song C; Tao Y; Tu S; Fang J; Chen T; Sun C; Wu B Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):221-4. PubMed ID: 24666488 [TBL] [Abstract][Full Text] [Related]
23. Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival. Liu HL; Sun ZM; Geng LQ; Wang XB; Ding KY; Tang BI; Tong J; Wang ZY Bone Marrow Transplant; 2012 Sep; 47(9):1186-90. PubMed ID: 22246086 [TBL] [Abstract][Full Text] [Related]
24. Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML. Horn B; Baxter-Lowe LA; Englert L; McMillan A; Quinn M; Desantes K; Cowan M Bone Marrow Transplant; 2006 Feb; 37(3):263-9. PubMed ID: 16327813 [TBL] [Abstract][Full Text] [Related]
25. Engraftment of heavily transfused patients with severe aplastic anemia with a fludarabine-based regimen. Wang SB; Li L; Pan XH; Hu DM; Peng LH; Liu L; Xie ZJ; Yin B; Sun XJ; Yu J; Liang Y Clin Transplant; 2013; 27(2):E109-15. PubMed ID: 23387380 [TBL] [Abstract][Full Text] [Related]
26. Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation? Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Kim CK; Lee KT; Won JH; Hong DS Korean J Intern Med; 2016 Jul; 31(4):750-61. PubMed ID: 27017944 [TBL] [Abstract][Full Text] [Related]
27. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India. Choudhary D; Sharma SK; Gupta N; Kharya G; Pavecha P; Handoo A; Setia R; Katewa S Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007 [TBL] [Abstract][Full Text] [Related]
28. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Deeg HJ; Amylon ID; Harris RE; Collins R; Beatty PG; Feig S; Ramsay N; Territo M; Khan SP; Pamphilon D; Leis JF; Burdach S; Anasetti C; Hackman R; Storer B; Mueller B Biol Blood Marrow Transplant; 2001; 7(4):208-15. PubMed ID: 11349807 [TBL] [Abstract][Full Text] [Related]
29. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia. Kumar R; Prem S; Mahapatra M; Seth T; Chowdhary DR; Mishra P; Pillai L; Narendra AM; Mehra NK; Saxena R; Choudhry VP Bone Marrow Transplant; 2006 Apr; 37(8):745-9. PubMed ID: 16518427 [TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin. Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700 [TBL] [Abstract][Full Text] [Related]
32. Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective study. Kako S; Kanda Y; Onizuka M; Aotsuka N; Usuki K; Tachibana T; Kobayashi T; Kato J; Yano S; Shimizu H; Shono K; Tanaka M; Tsukamoto S; Mori T; Yamazaki E; Najima Y; Hangaishi A; Hoshino T; Watanabe R; Matsumoto K; Okamoto S; Am J Hematol; 2020 Mar; 95(3):251-257. PubMed ID: 31804748 [TBL] [Abstract][Full Text] [Related]
33. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. Bejanyan N; Kim S; Hebert KM; Kekre N; Abdel-Azim H; Ahmed I; Aljurf M; Badawy SM; Beitinjaneh A; Boelens JJ; Diaz MA; Dvorak CC; Gadalla S; Gajewski J; Gale RP; Ganguly S; Gennery AR; George B; Gergis U; Gómez-Almaguer D; Vicent MG; Hashem H; Kamble RT; Kasow KA; Lazarus HM; Mathews V; Orchard PJ; Pulsipher M; Ringden O; Schultz K; Teira P; Woolfrey AE; Saldaña BD; Savani B; Winiarski J; Yared J; Weisdorf DJ; Antin JH; Eapen M Blood Adv; 2019 Oct; 3(20):3123-3131. PubMed ID: 31648332 [TBL] [Abstract][Full Text] [Related]
34. Haploidentical haematopoietic stem cell transplantation using CD3 or CD3/CD19 depletion and conditioning with fludarabine, cyclophosphamide and antithymocyte globulin for acquired severe aplastic anaemia. Koh KN; Im HJ; Kim BE; Choi ES; Jang S; Kwon SW; Park CJ; Seo JJ Br J Haematol; 2012 Apr; 157(1):139-42. PubMed ID: 22055111 [No Abstract] [Full Text] [Related]
35. An Antithymocyte Globulin-Free Conditioning Regimen Using Fludarabine and Cyclophosphamide Is Associated with Good Outcomes in Patients Undergoing Matched Related Family Donor Transplantation for Aplastic Anemia. George B; Lionel S; Selvarajan S; Abubacker FN; Korula A; Devasia AJ; Kulkarni U; Lakshmi KM; Sindhuvi E; Abraham A; Mathews V Transplant Cell Ther; 2021 May; 27(5):409.e1-409.e6. PubMed ID: 33965181 [TBL] [Abstract][Full Text] [Related]
36. Successful Outcome With Fludarabine-Based Conditioning Regimen for Hematopoietic Stem Cell Transplantation From Related Donor in Fanconi Anemia: A Single Center Experience From Turkey. Kuşkonmaz B; Ünal Ş; Bayhan T; Aytaç Eyüboğlu S; Tavil B; Çetin M; Gümrük F; Uçkan Çetinkaya D Pediatr Blood Cancer; 2016 Apr; 63(4):695-700. PubMed ID: 26703084 [TBL] [Abstract][Full Text] [Related]
37. Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia. Raida L; Tucek P; Faber E; Vondrakova J; Rusinakova Z; Skoumalova I; Hubacek J; Jarosova M; Katrincsakova B; Pikalova Z; Kurfurst P; Indrak K Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Dec; 155(4):327-32. PubMed ID: 22336644 [TBL] [Abstract][Full Text] [Related]
38. [Clinical analysis of haploidentical or unrelated donor hematopoietic stem cell transplantation for patients with severe aplastic anemia]. Chen HR; Lou JX; Zhang Y; Liu XD; Yang K; Chen P; Liu B; He XP; Guo Z; Liu D Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):959-64. PubMed ID: 22931664 [TBL] [Abstract][Full Text] [Related]
39. Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT. Cable C; Buzzeo MP; Schold JD; Khan S; Leather H; Moreb J; Jamieson K; Scornik J; Amdur RJ; Wingard JR; Reddy V Bone Marrow Transplant; 2010 Jan; 45(1):31-7. PubMed ID: 19543325 [TBL] [Abstract][Full Text] [Related]
40. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M; Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]